Nunavut – The Governments of Canada and Nunavut signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $7.3 million over three years to improve access to new drugs for rare diseases for residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the Government of Canada announced …
Drugs for Rare Diseases – Nova Scotia Agreement
Nova Scotia – The Governments of Canada and Nova Scotia signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $39 million over three years to improve access to new drugs for rare diseases for Nova Scotia residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the Government …
Drugs for Rare Diseases – New Brunswick Agreement
New Brunswick – Governments of Canada and the province of New Brunswick signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest over $32 million over three years to improve access to new drugs for rare diseases for New Brunswick residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March …
Drugs for Rare Diseases – Newfoundland and Labrador Agreement
Ottawa – Governments of Canada and Newfoundland and Labrador signed the National Strategy for Drugs for Rare Disease (DRD) agreement to invest a total amount of over $22 million over three years to improve access to new drugs for rare diseases for its residents and to support enhanced access to existing drugs, early diagnosis, and screening for rare diseases. In March 2023, the …